Vistagen Therapeutics: Pioneering Future CNS Treatments Amid Biotech Volatility
Vistagen Therapeutics, a clinical-stage biopharmaceutical company, is pioneering innovative treatments for central nervous system disorders, offering hope to patients and investors alike in the rapidly evolving biotech landscape.
3 minutes to read